D-SIGHT
- Biotech or pharma, therapeutic R&D
D-Sight is a clinical-stage biotech company pioneering a first-in-class neuroprotective eye drop for early intervention in diabetic retinopathy and glaucoma—two of the leading causes of preventable blindness globally, affecting over 300 million people.